Hematopoietic Stem Cell Transplantation in Children with Autoimmune Connective Tissue Diseases

  • Magdalena Witkowska
  • Elzbieta Smolewska
  • Piotr Smolewski


Autoimmune connective tissue diseases (ACTDs) are heterogeneous disorders associated with different manifestations, clinical course of disease and prognosis among patients. Although recent advances in understanding the pathogenesis have led to major progress in target-oriented therapy, they still remain incurable. Novel biological drugs, cellular therapy and hematopoietic stem cell transplantation (HSCT) are real hopes for treatment development in the future. The concept of both autologous and allogeneic HSCT in children with autoimmune diseases is developing energetically since 1996, when the first HSCT was performed. Nowadays, after 17 years of clinical experience, both types of HSCT remain attractive and powerful salvage methods of treatment. However, there are still many doubts and unclear issues, which need further investigation. In the present review, we provide an overview of the knowledge concerning actual data on HSCT in a pediatric group of patients with different ACTDs, focused on juvenile idiopathic arthritis, systemic lupus erythematosus and systemic sclerosis.


Autoimmune connective tissue diseases Children Treatment Hematopoietic stem cell transplantation 



This work was partially supported by the Grants No. 503/8-000-01/503-01 and No 503/8-093-01/503-01 from the Medical University of Lodz, Poland.


  1. Adib N, Silman A, Thomson W (2005) Outcome following onset of juvenile idiopathic inflammatory arthritis: II. Predictors of outcome in juvenile arthritis. Rheumatology 44:1002–1007PubMedCrossRefGoogle Scholar
  2. Appelbaum FR (2001) Haematopoietic cell transplantation as immunotherapy. Nature 411:385–389PubMedCrossRefGoogle Scholar
  3. Balbir-Gurman A, Braun-Moscovici Y (2012) Scleroderma—new aspects in pathogenesis and treatment. Best Pract Res Clin Rheumatol 26:13–24PubMedCrossRefGoogle Scholar
  4. Baldwin JL, Storb R, Thomas ED et al (1977) Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthr Rheum 20:1043–1048CrossRefGoogle Scholar
  5. Bargetzi MJ, Schönenberger A, Tichelli A et al (1997) Celiac disease transmitted by allogeneic non-T cell-depleted bone marrow transplantation. Bone Marrow Transpl 20:607–609CrossRefGoogle Scholar
  6. Bennett CL (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX) is caused by mutations FOXP3. Nat Genet 27:20–21PubMedCrossRefGoogle Scholar
  7. Berisso GA, van Lint MT, Bacigalupo A et al (1999) Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves’ disease. Bone Marrow Transpl 23:1091–1092CrossRefGoogle Scholar
  8. Bezalel S, Asher I, Elbirt D et al (2012) Novel biological treatments for systemic lupus erythematosus: current and future modalities. Isr Med Assoc J 14:508–514PubMedGoogle Scholar
  9. Brinkman DM, de Kleer IM, ten Cate R et al (2007) Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. Arthr Rheum 56:2410–2421CrossRefGoogle Scholar
  10. Chen J, Wang Y, Kunkel G et al (2005) Use of CD34+ autologous stem cell transplantation in the treatment of children with refractory systemic lupus erythematosus. Clin Rheumatol 24:464–468PubMedCrossRefGoogle Scholar
  11. Cohen A, Békássy AN, Gaiero A et al (2008) Endocrinological late complications after hematopoietic SCT in children. Bone Marrow Transpl 41(Suppl 2):S43–S48CrossRefGoogle Scholar
  12. De Kleer IM, Brinkman DM, Ferster A et al (2004) Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis 63:1318–1326PubMedCentralPubMedCrossRefGoogle Scholar
  13. El Bahri DM, Meddeb N, Sellami S (2007) Rheumatoid arthritis: current status of therapy. Tunis Med 85:1–8PubMedGoogle Scholar
  14. Falkenburg JH, Warren EH (2011) Graft versus leukemia reactivity after allogeneic stem cell transplantation. Biol Blood Marrow Transpl 17:33–38CrossRefGoogle Scholar
  15. Farge D, Passweg J, van Laar JM et al (2004) Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR registry. Ann Rheum Dis 63:974–981PubMedCentralPubMedCrossRefGoogle Scholar
  16. Farge D, Labopin M, Tyndall A et al (2010) Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 95:284–292PubMedCentralPubMedCrossRefGoogle Scholar
  17. Ferreira RA, Vastert SJ, Abinun M et al (2006) Hemophagocytosis during fludarabine-based SCT for systemic juvenile idiopathic arthritis. Bone Marrow Transpl 38:249–251CrossRefGoogle Scholar
  18. Gurevitz SL, Snyder JA, Wessel EK et al (2013) Systemic lupus erythematosus: a review of the disease and treatment options. Consult Pharm 28:110–121PubMedCrossRefGoogle Scholar
  19. Habibi S, Saleem MA, Ramanan AV (2011) Juvenile systemic lupus erythematosus: review of clinical features and management. Indian Pediatr 48:879–887PubMedCrossRefGoogle Scholar
  20. Hari P, Bagga A, Mahajan P et al (2009) Outcome of lupus nephritis in Indian children. Lupus 18:348–354PubMedCrossRefGoogle Scholar
  21. Hashkes PJ, Wright BM, Lauer MS et al (2010) Mortality outcomes in pediatric rheumatology in the US. Arthr Rheum 62:599–608Google Scholar
  22. Hinterberger W, Hinterberger-Fischer M, Marmont A (2002) Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transpl 30:753–759CrossRefGoogle Scholar
  23. Holzer U, van Royen-Kerkhof A, van der Torre P et al (2010) Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis. Scand J Rheumatol 39:88–92PubMedCrossRefGoogle Scholar
  24. Huang JL (2012) New advances in juvenile idiopathic arthritis. Chang Gung Med J 35:1–14PubMedGoogle Scholar
  25. Ikehara S (2002) Bone marrow transplantation: a new strategy for intractable diseases. Drugs Today 38:103–111PubMedCrossRefGoogle Scholar
  26. Jayne D, Passweg J, Marmont A et al (2004) Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 13:168–176PubMedCrossRefGoogle Scholar
  27. Kahn P (2012) Juvenile idiopathic arthritis: an update for the clinician. Bull NYU Hosp Jt Dis 70:152–166PubMedGoogle Scholar
  28. Knaan-Shanzer S, Houben P, Kinwel-Bohré EP et al (1991) Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transpl 8:333–338Google Scholar
  29. Kowal-Bielecka O, Landewe R, Avouac J et al (2009) EULAR recommendations for the treatment of systemic sclerosis: a report from EULAR Scleroderma Trials and Research Group (EUSTAR). Ann Rheum Dis 68:620–628PubMedCrossRefGoogle Scholar
  30. Kumar A, Marwaha V, Grover R (2003) Emergencies in rheumatology. J Indian Med Assoc 101:520–524PubMedGoogle Scholar
  31. Locatelli F, Nöllke P, Zecca M et al (2005) Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 105:410–419PubMedCrossRefGoogle Scholar
  32. Malleson PN, Fung MY, Rosenberg AM et al (1996) The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol 23:1981–1987PubMedGoogle Scholar
  33. Manno R, Boin F (2010) Immunotherapy of systemic sclerosis. Immunotherapy 2:863–878PubMedCentralPubMedCrossRefGoogle Scholar
  34. Marazuela M, Steegman JL (2000) Transfer of autoimmune hypothyroidism following bone marrow transplantation from a donor with Graves’ disease. Bone Marrow Transpl 26:1217–1220CrossRefGoogle Scholar
  35. Marmont MA (1998) Stem cell transplantation for severe autoimmune diseases: progress and problems. Haematologica 83:733–743PubMedGoogle Scholar
  36. Marmont MA (2004) Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications. Best Pract Res Clin Haematol 17:223–232PubMedCrossRefGoogle Scholar
  37. Mckendry RJ, Huebsch L, Leclair B (1996) Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year follow-up. Arthr Rheum 39:1246–1253CrossRefGoogle Scholar
  38. McMahan R, Balfe LM, Greene L (2012) Summary of AHRQ’s comparative effectiveness review of disease-modifying antirheumatic drugs for children with juvenile idiopathic arthritis. J Manag Care Pharm 18(1 Suppl B):1–16PubMedGoogle Scholar
  39. Meloni G, Capria S, Vignetti M et al (1997) Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation. Blood 89:4659PubMedGoogle Scholar
  40. Niehues T, Lankisch P (2006) Recommendations for the use of methotrexate in juvenile idiopathic arthritis. Paediatr Drugs 8:347–356PubMedCrossRefGoogle Scholar
  41. Pession A, Zama D, Masetti R et al (2012) Hematopoietic stem cell transplantation for curing children with severe autoimmune diseases: is this a valid option? Pediatr Transpl 16:413–425CrossRefGoogle Scholar
  42. Petty RE (1999) Prognosis in children with rheumatic disease: justification for consideration of new therapies. Rheumatology 38:739–742PubMedCrossRefGoogle Scholar
  43. Rabusin M, Andolina M, Maximova N et al (2008) Haematopoietic SCT in autoimmune diseases in children: rationale and new perspectives. Bone Marrow Transpl 41(Suppl 2):S96–S99CrossRefGoogle Scholar
  44. Rabusin M, Andolina M, Maximova N (2011) Haematopoietic stem cell transplantation with refractory autoimmune cytopenia: a retrospective analysis from EBMT registry. Bone Marrow Transpl 46:377Google Scholar
  45. Raj R, Murin S, Matthay R et al (2002) Systemic lupus erythematosus in the intensive care unit. Crit Care Clin 18:781–803PubMedCrossRefGoogle Scholar
  46. Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369:767–778PubMedCrossRefGoogle Scholar
  47. Redlich K, Schett G, Steiner G et al (2003) Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade. Arthr Rheum 48:3308–3319CrossRefGoogle Scholar
  48. Scalapino K, Arkachaisri T, Lucas M et al (2006) Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol 33:1004–1013PubMedGoogle Scholar
  49. Seidel MG, Ernst U, Printz D et al (2006) Expression of the putatively regulatory T-cell marker FOXP3 by CD4+ CD25+ T cells after pediatric hematopoietic stem cell transplantation. Haematologica 91:566–569PubMedGoogle Scholar
  50. Snowden JA, Saccardi R, Allez M et al (2012) Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for blood and marrow transplantation. Bone Marrow Transpl 47:770–790CrossRefGoogle Scholar
  51. Sykes M, Nikolic B (2005) Treatment of severe autoimmune disease by stem-cell transplantation. Nature 435:620–627PubMedCrossRefGoogle Scholar
  52. Tapprich C, Feuk R, Schneider P et al (2003) Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma. Bone Marrow Transpl 32:629–631CrossRefGoogle Scholar
  53. Torok KS (2012) Pediatric scleroderma: systemic or localized forms. Pediatr Clin North Am 59:381–405PubMedCentralPubMedCrossRefGoogle Scholar
  54. Toussirot E, Streit G, Wendling D (2007) Infectious complications with anti-TNFalpha therapy in rheumatic diseases: a review. Recent Pat Inflamm Allergy Drug Discov 1:39–47PubMedCrossRefGoogle Scholar
  55. van Bekkum DW (1993) BMT in experimental autoimmune diseases. Bone Marrow Transpl 11:183–187Google Scholar
  56. van Bekkum DW (2000) Stem cell transplantation in experimental models of autoimmune disease. J Clin Immunol 20:10–16PubMedCrossRefGoogle Scholar
  57. van Bekkum DW (2004) Stem cell transplantation for autoimmune disorders. Preclinical experiments. Best Pract Res Clin Haematol 17:201–222PubMedCrossRefGoogle Scholar
  58. van Bekkum DW, Bohre EP, Houben PF et al (1989) Regression of adjuvant-induced arthritis in rats following bone marrow transplantation. Proc Natl Acad Sci USA 86:10090–10094PubMedCentralPubMedCrossRefGoogle Scholar
  59. Vonk MC, Marjanovic Z, van den Hoogen FM et al (2008) Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. Ann Rheum Dis 67:98–104PubMedCrossRefGoogle Scholar
  60. Yel L (2010) Selective IgA deficiency. J Clin Immunol 30:10–16PubMedCentralPubMedCrossRefGoogle Scholar
  61. Zeher M, Papp G, Szodoray P (2011) Autologous haemopoietic stem cell transplantation for autoimmune diseases. Expert Opin Biol Ther 11:1193–1201PubMedCrossRefGoogle Scholar
  62. Zulian F, Martini G (2007) Childhood systemic sclerosis. Curr Opin Rheumatol 19:592–597PubMedCrossRefGoogle Scholar

Copyright information

© L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland 2014

Authors and Affiliations

  • Magdalena Witkowska
    • 1
  • Elzbieta Smolewska
    • 2
  • Piotr Smolewski
    • 1
  1. 1.Department of Experimental HematologyMedical University of LodzLodzPoland
  2. 2.Department of Pediatric Cardiology and RheumatologyMedical University of LodzLodzPoland

Personalised recommendations